Delivery Order SPE2DB20D3101-SPE2DB23FRYU7
Award Date 9/25/23
Potential Completion Date 9/26/23
Potential Value $95
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $109,820 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 tablets of 0.5 mg dexamethasone. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The period of performance is August 21-22, 2023. The Defense Logistics Agency manages the Department of Defense's supply chain and procurement programs, and this delivery order for a common corticosteroid medication supports the Agency's mission to...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $86.09 to Amerisourcebergen Drug Corp for the supply of 100 units of 4 mg dexamethasone tablets. As the prime contractor, Amerisourcebergen Drug Corp will deliver the pharmaceutical products from its facility located in Conshohocken, Pennsylvania under a one-day period of performance beginning on August 7, 2023. The order was placed utilizing Amerisourcebergen Corporation's Federal Supply Schedule contract vehicle...
- The Defense Logistics Agency awarded a $1,604 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 10 mg/ml vials of dexamethasone. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The single day order from August 23rd to 24th, 2023 is under an indefinite delivery/indefinite quantity contract vehicle held by Amerisourcebergen with DLA for pharmaceutical products and services. As a major supplier of medical materiel to the Department of...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $504.08 to Amerisourcebergen Drug Corporation for 100 tablets of 4 mg dexamethasone. The place of performance is Conshohocken, Pennsylvania. The period of performance is July 11-12, 2023. The Defense Logistics Agency is the logistics combat support agency of the Department of Defense, responsible for worldwide logistics support in procurement, distribution, and maintenance for all military services and several...
- The Defense Logistics Agency awarded a $54,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 mg/30 ml vials of dexamethasone. The single award was issued against an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and DoD customers. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in August 2023. No subcontractors or set aside designations were identified. The...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at fifty thousand five hundred forty dollars to Amerisourcebergen Drug Corporation for one hundred tablets of 2 mg dexamethasone. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will fulfill the order from its facility in Conshohocken, Pennsylvania over a period of one day beginning on August 2, 2023. The Defense Logistics Agency routinely issues such orders under various...
- The Defense Logistics Agency Troop Support Medical awarded a $118,370 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 boxes containing 1 milligram dexamethasone tablets each. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance for this order is one day, from July 31, 2023 through August 1, 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency manages the...
- The Defense Logistics Agency awarded a $459.94 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division on August 16, 2023. Under the contract, Amerisourcebergen will provide 100 tablets of 4 mg dexamethasone to an unspecified customer. The place of performance is Conshohocken, Pennsylvania, and all goods and services must be delivered by August 17, 2023. No additional context was provided regarding the Defense Logistics Agency's programs or any associated...
- The Defense Logistics Agency awarded a $64,800 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120mg/30ml vials of dexamethasone. The single award was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DOD components. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three-day period in early August 2023. As a major provider of medical supplies to the U.S....
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $624 to Amerisourcebergen Drug Corporation for 100 tablets of 4 mg dexamethasone. The place of performance is Conshohocken, Pennsylvania. The period of performance is September 18-19, 2023. Dexamethasone is a corticosteroid medication commonly used to treat conditions such as arthritis, asthma, severe allergies, and certain cancers. The Defense Logistics Agency manages the global supply chain for the...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FRYU7Delivery Order
The Defense Logistics Agency awarded a $95,180 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 tablets of 4 mg dexamethasone. The place of performance is Conshohocken, Pennsylvania. The period of performance is September 25-26, 2023. DLA procures pharmaceuticals and medical supplies to support the Department of Defense. Under this order, Amerisourcebergen will deliver a generic corticosteroid drug to an unspecified DLA customer, likely for treatment of inflammation or allergic reactions. No subcontractors or set aside designations were identified.
Generated 12/25/23, 9:25 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $95 | 9/25/23 |